Haiti vs Montenegro: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Haiti
39.0%
in 2025
Montenegro
28.0%
in 2025
Haiti rank
160th
Montenegro rank
162nd
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Haiti
- Montenegro
How they compare
Haiti currently reports 39.0% against 28.0% in Montenegro, a difference of 11.0%.
That makes Haiti's figure about 1.4 times Montenegro's.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Montenegro ahead.
Haiti ranks 160th and Montenegro ranks 162nd of 194 countries.
Haiti has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Haiti | Montenegro | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 3.9% | 0.0% | 3.9% | Haiti |
| 2020s | 46.2% | 4.7% | 41.5% | Haiti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Haiti or Montenegro?
- Haiti, at 39.0% against 28.0% in Montenegro as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Haiti and Montenegro?
- 11.0%, with Haiti ahead.
- How many years of comparable data are there for Haiti and Montenegro?
- 18 years are reported by both, from 2008 to 2025.
- How do Haiti and Montenegro rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Haiti ranks 160th and Montenegro ranks 162nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.